Vol. 13. Núm. 34.
Páginas 1943-1953 (Mayo 2021)

Actualización
Vasculitis

Vasculitis

P. Fanlo MateoaL.F. Flores-Suárezb
Doi : https://10.1016/j.med.2021.05.007
Opciones
Resumen

Las vasculitis son entidades clinicopatológicas que se definen por la presencia de inflamación de las paredes de los vasos sanguíneos. Las diferentes formas de vasculitis pueden variar en función de la etiología, patogénesis, tipo y calibre del vaso afectado, tipo de inflamación, distribución orgánica preferente, manifestaciones clínicas, predisposición genética y características demográficas. La clasificación actual vigente más utilizada se basa en las definiciones nominales propuestas por la Conferencia de Consenso Internacional de Chapel Hill (CHCC) en su revisión del año 2012. La etiología de las vasculitis en la actualidad, a pesar de los recientes progresos en el estudio de la genética y de la patogénesis, no está completamente entendida. Debido a la variabilidad de las vasculitis, no existe un único y uniforme método diagnóstico. El diagnóstico de las vasculitis en la mayoría de las ocasiones suele ser un reto. Sin embargo, una detallada historia clínica, una exploración física cuidadosa y unas pruebas de laboratorios adecuadas y acordes con la información obtenida con lo anterior, son necesarias en todos los tipos de vasculitis para determinar el diagnóstico correcto, su fecha y forma de inicio probable, los órganos o sistemas afectados y la extensión de la enfermedad.

Palabras clave
Vasculitis sistémicas
Anticuerpos anticitoplasma de neutrófilo
Hemorragia pulmonar
Púrpura
Aortitis
Abstract

Vasculitis is a group of clinicopathological entities involving inflammation of the blood vessel walls. The different forms of vasculitis may vary in terms of aetiology, pathogenesis, type, and calibre of vessel involved, type of inflammation, preferential organ distribution, clinical manifestations, genetic predisposition, and demographic characteristics. The classification most widely used currently is based on the nominal definitions proposed by the International Chapel Hill Consensus Conference (CHCC) in its 2012 revision. The aetiology of vasculitis is still not fully understood, despite recent advances in the study of genetics and pathogenesis. Due to the variability of vasculitis, there is no single, uniform diagnostic method. Diagnosis of vasculitis is challenging in most cases. However, a detailed clinical history, careful physical examination and appropriate laboratory tests from the information obtained from them are necessary in all types of vasculitis to establish a correct diagnosis, its probable date and manner of onset, the organs or systems affected and the extent of disease.

Keywords
Systemic vasculitis
Anti-neutrophil cytoplasmic antibodies
Pulmonary haemorrhage
Purpura
Aortitis

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
M. Stanton, V. Tiwari.
Polyarteritis Nodosa.
En: StatPearls [Internet], StatPearls Publishing, (2020),
[2]
P.M. ZEEK.
Periarteritis nodosa and other forms of necrotizing angiitis.
N Engl J Med., (1953), 248 pp. 764-772
[3]
G.G. Hunder, W.P. Arend, D.A. Bloch, L.H. Calabrese, A.S. Fauci, J.F. Fries, et al.
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction.
Arthritis Rheum., (1990), 33 pp. 1065-1067
[4]
J.C. Jennette, R.J. Falk, K. Andrassy, P.A. Bacon, J. Churg, W.L. Gross, et al.
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.
Arthritis Rheum., (1994), 37 pp. 187-192
[5]
J.C. Jennette, R.J. Falk, P.A. Bacon, N. Basu, M.C. Cid, F. Ferrario, et al.
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
Arthritis Rheum., (2013), 65 pp. 1-11
[6]
P.A. Renauer
202106080541335878
, G. Saruhan-Direskeneli, P. Coit, A. Adler, K. Aksu, G. Keser, et al.
Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in Takayasu arteritis in a genome-wide association study.
Arthritis Rheumatol., (2015), 67 pp. 1361-1368
[7]
H.C. Kuo, S.C. Li, M.M. Guo, Y.H. Huang, H.R. Yu, F.C. Huang, et al.
Genome-wide association study identifies novel susceptibility genes associated with coronary artery aneurysm formation in Kawasaki disease.
PLoS One., (2016), 11 pp. e0154943
[8]
Y.C. Kwon, J.J. Kim, S.W. Yun, J.J. Yu, K.L. Yoon, K.Y. Lee, et al.
Korean Kawasaki disease genetics consortium. BCL2L11 is associated with Kawasaki disease in intravenous immunoglobulin responder patients.
Circ Genom Precis Med., (2018), 11 pp. e002020
[9]
P.A. Merkel, G. Xie, P.A. Monach, X. Ji, D.J. Ciavatta, J. Byun, et al.
Vasculitis clinical research consortium. Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis.
Arthritis Rheumatol., (2017), 69 pp. 1054-1066
[10]
P.A. Lyons, T.F. Rayner, S. Trivedi, J.U. Holle, R.A. Watts, D.R. Jayne, et al.
Genetically distinct subsets within ANCA-associated vasculitis.
N Engl J Med., (2012), 367 pp. 214-223
[11]
R. López-Mejías, F.D. Carmona, S. Castañeda, F. Genre, S. Remuzgo-Martínez, B. Sevilla-Perez, et al.
A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.
[12]
Y. Fei, R. Webb, B.L. Cobb, H. Direskeneli, G. Saruhan-Direskeneli, A.H. Sawalha.
Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study.
Arthritis Res Ther., (2009), 11 pp. R66
[13]
Y. Kirino, G. Bertsias, Y. Ishigatsubo, N. Mizuki, I. Tugal-Tutkun, E. Seyahi, et al.
Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.
Nat Genet., (2013), 45 pp. 202-207
[14]
P. Renauer, P. Coit, A.H. Sawalha.
Epigenetics and vasculitis: a comprehensive review.
Clin Rev Allergy Immunol., (2016), 50 pp. 357-366
[15]
C.A. Langford.
Vasculitis.
J Allergy Clin Immunol., (2010), 125 pp. S216-S225
[16]
X. Bosch
202106080541335879
2021060805413358710
, A. Guilabert, J. Font.
Antineutrophil cytoplasmic antibodies.
Lancet., (2006), 368 pp. 404-418
[17]
D. Jayne
2021060805413358711
2021060805413358712
.
Newer therapies in ANCA associated vasculitis.
Rev Clin Esp., (2020), 220 pp. 179-181
[18]
G. Hunder.
Vasculitis: diagnosis and therapy.
Am J Med., (1996), 100 pp. 37S-45S
[19]
E. Suresh.
Diagnostic approach to patients with suspected vasculitis.
Postgrad Med J., (2006), 82 pp. 483-488
[20]
I. Delevaux, M. Andre, M. Colombier, E. Albuisson, F. Meylheuc, R.J. Bègue, et al.
Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?.
Ann Rheum Dis., (2003), 62 pp. 337-340
[21]
S.J. Naides.
Known causes of vasculitis in man.
Cleve Clin J Med., (2002), 69 pp. SII15-SII19
[22]
M.L. Cuellar.
Drug-induced vasculitis.
Curr Rheumatol Rep., (2002), 4 pp. 55-59
[23]
H.K. Choi, P.A. Merkel, A.M. Walker, J.L. Niles.
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.
[24]
J. Graf.
Rheumatic manifestations of cocaine use.
Curr Opin Rheumatol., (2013), 25 pp. 50-55
[25]
S.J. Oh.
Diagnostic usefulness and limitations of the sural nerve biopsy.
Yonsei Med J., (1990), 31 pp. 1-26
[26]
A.W. Stanson, J.L. Friese, C.M. Johnson, M.A. McKusick, J.F. Breen, E.A. Sabater, et al.
Polyarteritis nodosa: spectrum of angiographic findings.
Radiographics., (2001), 21 pp. 151-159
[27]
W.A. Schmidt, E. Gromnica-Ihle.
What is the best approach to diagnosing large-vessel vasculitis?.
Best Pract Res Clin Rheumatol., (2005), 19 pp. 223-242
[28]
J.M. Calvo-Romero.
Giant cell arteritis.
Postgrad Med J., (2003), 79 pp. 511-515
[29]
A. Hata, M. Noda, R. Moriwaki, F. Numano.
Angiographic findings of Takayasu arteritis: new classification.
Int J Cardiol., (1996), 54 pp. S155-S163
[30]
J. Savige, D. Gillis, E. Benson, D. Davies, V. Esnault, R.J. Falk, et al.
International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA).
Am J Clin Pathol., (1999), 111 pp. 507-513
[31]
X. Bossuyt, J.W. Cohen Tervaert, Y. Arimura, D. Blockmans, L.F. Flores-Suárez, et al.
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.
Nat Rev Rheumatol., (2017), 13 pp. 683-692
[32]
J.H. Stone, M. Talor, J. Stebbing, M.L. Uhlfelder, N.R. Rose, K.A. Carson, et al.
Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions.
[33]
L. Guillevin, B. Durand-Gasselin, R. Cevallos, M. Gayraud, F. Lhote, P. Callard, et al.
Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.
[34]
W.L. Gross, A. Trabandt, E. Reinhold-Keller.
Diagnosis and evaluation of vasculitis.
Rheumatology (Oxford)., (2000), 39 pp. 245-252
[35]
L. Guillevin, T. Dörner.
Vasculitis: mechanisms involved and clinical manifestations.
Arthritis Res Ther., (2007), 9 pp. S9
[36]
P. Ciéslik, A. Hrycek, P. Kłucínski.
Vasculopathy and vasculitis in systemic lupus erythematosus.
Pol Arch Med Wewn., (2008), 118 pp. 57-63
[37]
C. Pagnoux, P. Cohen, L. Guillevin.
Vasculitides secondary to infections.
Clin Exp Rheumatol., (2006), 24 pp. S71-S81
[38]
L.E. Mertz, D.L. Conn.
Vasculitis associated with malignancy.
Curr Opin Rheumatol., (1992), 4 pp. 39-46
[39]
D.S. Younger
2021060805413358713
2021060805413358714
.
Overview of the vasculitides.
Neurol Clin., (2019), 37 pp. 171-200